Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients
Open Access
- 2 May 2020
- preprint content
- other
- Published by Cold Spring Harbor Laboratory
Abstract
The COVID-19 pandemic continues to infect millions of people worldwide. In order to curb its spread and reduce morbidity and mortality, it is essential to develop sensitive and quantitative methods that identify infected individuals and enable accurate population-wide screening of both past and present infection. Here we show that Single Molecule Array assays detect seroconversion in COVID-19 patients as soon as one day after symptom onset using less than a microliter of blood. This multiplexed assay format allows us to quantitate IgG, IgM and IgA immunoglobulins against four SARS-CoV-2 targets, thereby interrogating 12 antibody isotype-viral protein interactions to give a high resolution profile of the immune response. Using a cohort of samples collected prior to the outbreak as well as samples collected during the pandemic, we demonstrate a sensitivity of 86% and a specificity of 100% during the first week of infection, and 100% sensitivity and specificity thereafter. This assay should become the gold standard for COVID19 serological profiling and will be a valuable tool for answering important questions about the heterogeneity of clinical presentation seen in the ongoing pandemic.Keywords
This publication has 23 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patientsJournal of Infection, 2020
- In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging TrendsDiagnostics, 2020
- Evaluations of serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreakPublished by Cold Spring Harbor Laboratory ,2020
- The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosisPublished by Cold Spring Harbor Laboratory ,2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control studyPublished by Cold Spring Harbor Laboratory ,2020
- A serological assay to detect SARS-CoV-2 seroconversion in humansPublished by Cold Spring Harbor Laboratory ,2020
- A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patientsPublished by Cold Spring Harbor Laboratory ,2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020